Cargando…

MiRNA as a Potential Target for Multiple Myeloma Therapy–Current Knowledge and Perspectives

Multiple myeloma (MM) is the second most common hematological malignancy. Despite the huge therapeutic progress thanks to the introduction of novel therapies, MM remains an incurable disease. Extensive research is currently ongoing to find new options. MicroRNAs (miRNAs) are small, non-coding RNA mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szudy-Szczyrek, Aneta, Ahern, Sean, Krawczyk, Janusz, Szczyrek, Michał, Hus, Marek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503263/ https://www.ncbi.nlm.nih.gov/pubmed/36143213 http://dx.doi.org/10.3390/jpm12091428

Ejemplares similares

Therapeutic Potential of Innate Lymphoid Cells for Multiple Myeloma Therapy
por: Szudy-Szczyrek, Aneta, et al.
Publicado: (2021)

Circulating Serum MiRNA-8074 as a Novel Prognostic Biomarker for Multiple Myeloma
por: Szudy-Szczyrek, Aneta, et al.
Publicado: (2022)

Polymorphisms in the promoter region of the CRBN gene as a predictive factor for the first-line CTD therapy in multiple myeloma patients
por: Szudy-Szczyrek, Aneta, et al.
Publicado: (2018)

Chemotherapy-Related Differences in Cognitive Functioning and Their Biological Predictors in Patients with Multiple Myeloma
por: Bury-Kamińska, Magdalena, et al.
Publicado: (2021)

The Clinical Relevance of Selected Cytokines in Newly Diagnosed Multiple Myeloma Patients
por: Mielnik, Michał, et al.
Publicado: (2023)

The TT Genotype of the KIAA1524 rs2278911 Polymorphism Is Associated with Poor Prognosis in Multiple Myeloma
por: Szudy-Szczyrek, Aneta, et al.
Publicado: (2023)

Prognostic value of pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in multiple myeloma patients treated with thalidomide-based regimen
por: Szudy-Szczyrek, Aneta, et al.
Publicado: (2020)

Polymorphism of Baculoviral Inhibitor of Apoptosis Repeat-Containing 5 (BIRC5) Can Be Associated with Clinical Outcome of Non-Small Cell Lung Cancer
por: Szczyrek, Michał, et al.
Publicado: (2022)

Polymorphisms in the Gene Encoding Caspase 8 May Predict the Response to First-Line Platinum-Based Chemotherapy in Locally Advanced or Advanced Non-Small-Cell Lung Cancer
por: Szczyrek, Michał, et al.
Publicado: (2021)

The impact of ACE gene polymorphism on the incidence and phenotype of sarcoidosis in rural and urban settings
por: Kieszko, Robert, et al.
Publicado: (2015)

Polymorphisms of Genes Encoding Multidrug Resistance Proteins as a Predictive Factor for Second-Line Docetaxel Therapy in Advanced Non-small Cell Lung Cancer
por: Szczyrek, Michał, et al.
Publicado: (2016)

Pleural Neoplasms—What Could MRI Change?
por: Szczyrek, Michał, et al.
Publicado: (2023)

The Association of GSTT1, GSTM1, and TNF-α Polymorphisms With the Risk and Outcome in Multiple Myeloma
por: Zmorzyński, Szymon, et al.
Publicado: (2019)

Real-World Efficacy of Midostaurin in Aggressive Systemic Mastocytosis
por: Szudy-Szczyrek, Aneta, et al.
Publicado: (2021)

Methylation of DROSHA and DICER as a Biomarker for the Detection of Lung Cancer
por: Szczyrek, Michał, et al.
Publicado: (2021)

ACE Insertion/Deletion Polymorphism (rs4646994) Is Associated With the Increased Risk of Multiple Myeloma
por: Zmorzynski, Szymon, et al.
Publicado: (2019)

The Impact of the NOD2/CARD15 Variant (3020insC) and PSMA6 Polymorphism (-8C>G) on the Development and Outcome of Multiple Myeloma
por: Zmorzyński, S., et al.
Publicado: (2020)

The Role of the Selected miRNAs as Diagnostic, Predictive and Prognostic Markers in Non-Small-Cell Lung Cancer
por: Szczyrek, Michał, et al.
Publicado: (2022)

The Relationship of ABCB1/MDR1 and CYP1A1 Variants with the Risk of Disease Development and Shortening of Overall Survival in Patients with Multiple Myeloma
por: Zmorzynski, Szymon, et al.
Publicado: (2021)

The Relationship of CCL5 and CCR1 Variants with Response Rate and Survival Taking into Account Thalidomide/Bortezomib Treatment in Patients with Multiple Myeloma
por: Popek-Marciniec, Sylwia, et al.
Publicado: (2023)

Association of Chromosome 17 Aneuploidy, TP53 Deletion, Expression and Its rs1042522 Variant with Multiple Myeloma Risk and Response to Thalidomide/Bortezomib Treatment
por: Popek-Marciniec, Sylwia, et al.
Publicado: (2023)

Neutrophil-to-Lymphocyte Ratio as a Factor Predicting Radiotherapy Induced Oral Mucositis in Head Neck Cancer Patients Treated with Radiotherapy
por: Homa-Mlak, Iwona, et al.
Publicado: (2021)

Diet, Microbiome, and Cancer Immunotherapy—A Comprehensive Review
por: Szczyrek, Michał, et al.
Publicado: (2021)

Effect of TOP2A and ERCC1 gene polymorphisms on the efficacy and toxicity of cisplatin and etoposide-based chemotherapy in small cell lung cancer patients
por: Nicoś, Marcin, et al.
Publicado: (2020)

Endocrine Adverse Events of Nivolumab in Non-Small Cell Lung Cancer Patients—Literature Review
por: Dudzińska, Marta, et al.
Publicado: (2020)

Do endocrine adverse events predict longer progression-free survival among patients with non-small-cell lung cancer receiving nivolumab?
por: Chmielewska, Izabela, et al.
Publicado: (2021)

Roles of miRNA dysregulation in the pathogenesis of multiple myeloma
por: Chen, Dan, et al.
Publicado: (2021)

High Level of Irisin as a Marker of Malnutrition in Head and Neck Cancer Patients Subjected to Radiotherapy
por: Homa-Mlak, Iwona, et al.
Publicado: (2022)

Promoter polymorphisms of TOP2A and ERCC1 genes as predictive factors for chemotherapy in non‐small cell lung cancer patients
por: Grenda, Anna, et al.
Publicado: (2019)

miRNA Studies in Glaucoma: A Comprehensive Review of Current Knowledge and Future Perspectives
por: Dobrzycka, Margarita, et al.
Publicado: (2023)

The efficacy of T790M mutation testing in liquid biopsy—Real clinic data
por: Krawczyk, Paweł, et al.
Publicado: (2022)

Exosomal miRNAs in the Tumor Microenvironment of Multiple Myeloma
por: Alipoor, Shamila D., et al.
Publicado: (2023)

The Application of Extracellular Vesicles Mediated miRNAs in Osteoarthritis: Current Knowledge and Perspective
por: Shang, Xiaobin, et al.
Publicado: (2022)

Paired miRNA- and messenger RNA-sequencing identifies novel miRNA-mRNA interactions in multiple myeloma
por: Aass, Kristin Roseth, et al.
Publicado: (2022)

Association of Chromosomal Translocation and MiRNA Expression with The Pathogenesis of Multiple Myeloma
por: Saki, Najmaldin, et al.
Publicado: (2014)

Expanding the repertoire of miRNAs and miRNA-offset RNAs expressed in multiple myeloma by small RNA deep sequencing
por: Agnelli, Luca, et al.
Publicado: (2019)

Circulating miRNA markers show promise as new prognosticators for multiple myeloma
por: Rocci, A, et al.
Publicado: (2014)

Identification of candidate targets and mechanisms involved in miRNA regulation in multiple myeloma
por: Yang, Yang, et al.
Publicado: (2022)

Remyelination in multiple sclerosis from the miRNA perspective
por: Maciak, Karina, et al.
Publicado: (2023)

In Silico Characterization of miRNA and Long Non-Coding RNA Interplay in Multiple Myeloma
por: Ronchetti, Domenica, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_se9c56qb590dgvmt1k3s75lv11